
Apellis Pharma (APLS) Latest News & Updates
Explore latest Apellis Pharma (APLS) News and Updates
Stay updated on Apellis Pharma (APLS) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Apellis Pharma (APLS)
Order type
Buy in
Order amount
Est. shares
0 shares

The Motley Fool •


Zacks Investment Research •

Investors Business Daily •


Seeking Alpha •

GlobeNewsWire •

The Motley Fool •

GlobeNewsWire •

GlobeNewsWire •

Apellis Announces Validation of Four Marketing Applications for Pegcetacoplan for Geographic Atrophy
GlobeNewsWire •

24/7 Wall Street •

GlobeNewsWire •

Zacks Investment Research •

Zacks Investment Research •

The Motley Fool •

Zacks Investment Research •


Zacks Investment Research •

24/7 Wall Street •



The Motley Fool •

Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewsWire •
